Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||LA / -|
Administered by: Other Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19
Diagnostic Lab Data:
CDC 'Split Type': SEPFIZER INC2021661876
Write-up: something reminiscent of erysipelas; This is a spontaneous report from a non-contactable consumer (patient). A 47-years-old male patient received BNT162B2 (COMIRNATY) in left arm, on 01Jun2021 at 16:00 (at 47 years of age), as first single dose, for COVID-19 immunisation. Medical history included COVID-19 infection. Patient had no known allergies. Concomitant medication included tick-borne encephalitis vaccine (TICK-BORNE ENCEPHALITIS VACCINE) taken for immunisation on 19May2021. The patient experienced something reminiscent of erysipelas on 04Jun2021 at 16:45 with outcome of unknown. Patient received treatment for the event with penicillin. The patient had not been tested for COVID-19 since the vaccination. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166